Latest News

Prognostic biomarkers: could they help doctors, patients and families to better navigate the end of life?

“We had to explain that the reason she had broken her hip was because she was getting weaker and essentially dying… At that stage knowing whether Mum had days or months left would have been [more]
Rare cancer care: Are European Reference Networks delivering on the promise?

With a bigger role for European Reference Networks foreseen for Europe’s post-pandemic future, we ask: are they fulfilling their mandate to improve the quality of diagnostics and care for patients with rare cancers? What value [more]
On a mission to beat cancer

What should be the priorities for the EU Cancer Mission? With the initial recommendations now open for comment and consultation, we hear from some of the players about the pitfalls and opportunities, and what they [more]
Malignant: Insights into the process of metastasis and how we can stop it

In the majority of cancers it is the metastases and not the primary tumour that prove fatal. Adriana Albini reviews steps in the malignant process and strategies to block it. Why and how do cancer [more]
Does it work for my patient? A pragmatic approach to building evidence on clinical effectiveness

Momentum is growing behind efforts to ensure new cancer therapies do not enter the market without any strategy for developing the evidence that patients and their doctors need to make informed decisions on whether it [more]